Yahoo
Tokyo - Delayed Quote JPY

Mani, Inc. (7730.T)

1,454.00 -88.00 (-5.71%)
At close: November 6 at 3:30:00 PM GMT+9
Chart Range Bar
Loading chart for 7730.T
  • Previous Close 1,542.00
  • Open 1,480.00
  • Bid 1,448.00 x --
  • Ask 1,455.00 x --
  • Day's Range 1,445.00 - 1,501.00
  • 52 Week Range 1,345.00 - 1,955.00
  • Volume 417,300
  • Avg. Volume 342,435
  • Market Cap (intraday) 143.223B
  • Beta (5Y Monthly) 0.35
  • PE Ratio (TTM) 19.79
  • EPS (TTM) 73.47
  • Earnings Date (est.) Jan 13, 2027
  • Forward Dividend & Yield 41.00 (2.82%)
  • 1y Target Est 1,887.14
  • Moby Rating Neutral

Mani, Inc. engages in the manufacture and supply of surgical and dental instruments in Japan, Asia, Europe, North America, and internationally. The company operates through three segments: Surgical Products, Eyeless Needle Products, and Dental Products. The company offers surgical instruments, such as maniplers, vessel knives, ENT knives, and stainless wire needles; and ophthalmic instruments, including ophthalmic sutures and knives, and trocar kits for vitrectomy. It also provides surgical eyeless, eyed, taper point, cutting, ophthalmic needles; and dental instruments, such as endodontic instruments, endodontic rotary instruments, root canal obturation, diamond and carbide burs, finishing and polishing instruments, sutures and surgical needles, endodontic micro-accessories, and endodontic accessories. Mani, Inc. was founded in 1956 and is headquartered in Utsunomiya, Japan.

www.mani.co.jp

--

Full Time Employees

August 31

Fiscal Year Ends

Healthcare

Sector

Recent News

View More

Performance Overview

Trailing total returns as of 11/6/2026, which may include dividends or other distributions. Benchmark is Nikkei 225 (^N225) .

YTD Return

7730.T
2.77%
Nikkei 225 (^N225)
14.09%

1-Year Return

7730.T
1.24%
Nikkei 225 (^N225)
12.87%

3-Year Return

7730.T
26.47%
Nikkei 225 (^N225)
75.60%

5-Year Return

7730.T
14.62%
Nikkei 225 (^N225)
93.96%

Earnings Trends

View More

Earnings Per Share (GAAP)

Revenue vs. Earnings

Annual
Quarterly
Annual
Quarterly
Q4 FY26
Revenue 8.62B
Earnings 1.59B
Profit Margin 18.50%

Q1

FY26

Q2

FY26

Q3

FY26

Q4

FY26

0
2B
4B
6B
8B
20.0%
22.0%
24.0%

Analyst Insights

View More

Analyst Price Targets

1,400.00
1,887.14 Average
1,454.00 Current
2,150.00 High

Analyst Recommendations

  • Strong Buy
  • Buy
  • Hold
  • Underperform
  • Sell

Statistics

View More

Valuation Measures

Annual
  • Market Cap

  • Enterprise Value

  • Trailing P/E

  • Forward P/E

  • PEG Ratio (current)

  • Price/Sales (ttm)

  • Price/Book (mrq)

  • Enterprise Value/Revenue

  • Enterprise Value/EBITDA

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    21.92%

  • Return on Assets (ttm)

    10.06%

  • Return on Equity (ttm)

    12.80%

  • Revenue (ttm)

    33.02B

  • Net Income Avi to Common (ttm)

    7.24B

  • Diluted EPS (ttm)

    73.47

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    26.5B

  • Total Debt/Equity (mrq)

    0.14%

  • Levered Free Cash Flow (ttm)

    9.68B

Company Insights

Research Reports

View More

People Also Watch

Mobilize your Website
View Site in Mobile | Classic
Share by: